Canada Flow Cytometry Market Size & Outlook, 2023-2030
Canada flow cytometry market, 2018-2030 (US$M)
Related Markets
Canada flow cytometry market highlights
- The Canada flow cytometry market generated a revenue of USD 166.0 million in 2023 and is expected to reach USD 292.7 million by 2030.
- The Canada market is expected to grow at a CAGR of 8.4% from 2024 to 2030.
- In terms of segment, instruments was the largest revenue generating product in 2023.
- Software is the most lucrative product segment registering the fastest growth during the forecast period.
Flow cytometry market data book summary
| Market revenue in 2023 | USD 166.0 million |
| Market revenue in 2030 | USD 292.7 million |
| Growth rate | 8.4% (CAGR from 2023 to 2030) |
| Largest segment | Instruments |
| Fastest growing segment | Software |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & Consumables, Software, Accessories, Services |
| Key market players worldwide | Danaher Corp, BD, Sysmex Corp, Agilent Technologies, Apogee Enterprises Inc, Bio-Rad Laboratories Inc Class A, Thermo Fisher Scientific Inc, Wipro Ltd ADR, Diasorin SpA, Miltenyi Biotec, Sony Group Corp |
Other key industry trends
- In terms of revenue, Canada accounted for 3.8% of the global flow cytometry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. flow cytometry market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 292.7 million by 2030.
Instruments was the largest segment with a revenue share of 35.54% in 2023. Horizon Databook has segmented the Canada flow cytometry market based on instruments, reagents & consumables, software, accessories, services covering the revenue growth of each sub-segment from 2018 to 2030.
Canada flow cytometry market is anticipated to grow at a lucrative CAGR during the forecast period. This high growth can be attributed to the increasing healthcare expenditure and expanding pharmaceutical industry in the country, which is expected to fuel the demand for flow cytometry products for research & clinical purposes.
However, a majority of Canadian pharmaceutical and biotechnology industry players are small- and medium-sized companies, which limits the adoption of innovative and advanced flow cytometry products in the country. Furthermore, extensive R&D initiatives being undertaken by local players for COVID-19 and cancer as a result of continuous public-private funding are anticipated to create lucrative opportunities for flow cytometry products in the country.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Flow Cytometry Market Scope
Flow Cytometry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada flow cytometry market size, by product, 2018-2030 (US$M)
Canada Flow Cytometry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
